BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6147367)

  • 1. Inotropic effect of prenalterol in amitriptyline poisoning.
    Heath A; Mårin P; Sjöstrand I
    Intensive Care Med; 1984; 10(4):209-11. PubMed ID: 6147367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological and clinical effects of prenalterol--a new inotropic beta-adrenoceptor stimulant. Proceedings of a symposium in Hamburg, December 5, 1980.
    Acta Med Scand Suppl; 1982; 659():1-325. PubMed ID: 6127881
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.
    Weiss A; Pfister B; Imhof P; Degen PH; Burckhardt D; Dubach UC
    Eur J Clin Pharmacol; 1980 Nov; 18(5):383-90. PubMed ID: 6108221
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prenalterol, hydrocortisone and insulin can be valuable in amitriptyline poisoning].
    Heath A; Sjöstrand I
    Lakartidningen; 1984 Feb; 81(9):793-4. PubMed ID: 6369049
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro studies on the cardiac activity of prenalterol with reference to use in congestive heart failure.
    Kenakin TP; Beek D
    J Pharmacol Exp Ther; 1982 Jan; 220(1):77-85. PubMed ID: 6118432
    [No Abstract]   [Full Text] [Related]  

  • 6. Echocardiographic comparison between prenalterol and dobutamine.
    Wester HA; Oltmanns D
    Acta Med Scand Suppl; 1982; 659():181-90. PubMed ID: 6127888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
    Manders WT; Vatner SF; Braunwald E
    J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of hypotension and bradycardia with prenalterol.
    Ostergaard D; Hüttemeier P; Pedersen T
    Anaesthesia; 1984 May; 39(5):494-5. PubMed ID: 6145369
    [No Abstract]   [Full Text] [Related]  

  • 9. [New drugs with positive inotropic action].
    Bijak A; Czołpiński T
    Kardiol Pol; 1982; 25(4):357-65. PubMed ID: 6128439
    [No Abstract]   [Full Text] [Related]  

  • 10. Selectivity of prenalterol for adrenergic receptor subtypes: a potential mechanism of inotropic selectivity.
    Williams RS
    J Cardiovasc Pharmacol; 1983; 5(2):266-71. PubMed ID: 6188901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenalterol is an agonist at beta 2- as well as at beta 1-adrenoceptors.
    Apperley GH; Drew GM; Sullivan AT
    Eur J Pharmacol; 1982 Jul; 81(4):659-63. PubMed ID: 6126381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of Prenalterol on left ventricular function of coronary patients].
    Javernaro A; Bolognesi R; Giacometti P; Potenza D; Cortesi G; Cucchini F
    Acta Biomed Ateneo Parmense; 1983; 54(1):17-8. PubMed ID: 6134412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and cardiometabolic effects of prenalterol in patients with acute myocardial infarction and shock.
    Reiz S; Friedman A; Häggmark S
    Acta Anaesthesiol Scand; 1981 Jun; 25(3):235-9. PubMed ID: 6119869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of prenaterol and cardiac glycosides in patients with recent myocardial infarction.
    Boström PA; Andersson J; Johansson BW; Lilja B; Thorell J; Tidfält K; Westerling S
    Eur J Clin Invest; 1984 Jun; 14(3):175-80. PubMed ID: 6147253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenalterol, a non-selective beta-adrenoceptor ligand with absolute beta1-selective partial agonist activity.
    Hedberg A; Mattsson H; Carlsson E
    J Pharm Pharmacol; 1980 Sep; 32(9):660-1. PubMed ID: 6107374
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemodynamic effects of a new beta-1 stimulating drug (prenalterol) in acute myocardial infarct in the open-chest pig].
    Branzi A; Binetti G; Specchia S; Magelli C; Zannoli R; Magnani B
    Cardiologia; 1982; 27(1):33-43. PubMed ID: 6152732
    [No Abstract]   [Full Text] [Related]  

  • 17. The lack of a pronounced preference of prenalterol for the beta-l-adrenoceptor subtype.
    Rohm N; Wagner J; Schümann HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):85-8. PubMed ID: 6113550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of beta-1-adrenergic agonists in the treatment of cardiac insufficiency].
    Coulombe D
    Ann Cardiol Angeiol (Paris); 1984; 33(4):207-10. PubMed ID: 6147113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
    Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
    Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenalterol in cardiogenic shock following acute myocardial infarction.
    Coma-Canella I; Lopez-Sendon J; Jadraque LM
    Am Heart J; 1984 Jun; 107(6):1195-201. PubMed ID: 6144265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.